603590.SH
康辰药业
SSE · Healthcare · Biotechnology · CN
CNY 30.12
−6.49%Aug 25, 2026, 10:32 UTC
Kangchen Pharmaceutical announced its first-half 2026 results: net profit attributable to shareholders was 95.7226 million yuan, up 5.14% year-on-year.
Source: